Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Lupin Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500257
ISIN Demat	INE326A01037
Book Value	576.33

NSE Code	LUPIN
Dividend Yield %	0.62
Market Cap	888227.67

P/E	17.04
EPS	114.11
Face Value	2


	BSE		NSE

05-Sep-2025

Last Price	1944.65
Net Change	5.25
% Change	0.27%
Prev.Close	1939.40
Open	1935.15
High	1970.00
Low	1932.70
Volume	25255

Last Price	1943.90
Net Change	4.7
% Change	0.24%
Prev.Close	1939.20
Open	1941.90
High	1970.00
Low	1932.00
Volume	319959

Value	49206815
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1970.00
52-Week High	2403.45
52-Week Low	1774.00

Value	623396288.1
Best Buy	0.00
Best Sell	1943.90
Best Quantity	0
Sell Quantity	62
Today's Range	1970.00
52-Week High	2402.90
52-Week Low	1795.20

Open Price	1947.40
High Price	1979.40
Low Price	1936.80
Last Price	1949.30
Prev Close	1947.70
Change	1.60
% Change	0.08 %

Average Price	1954.89
Underlying Value	1943.90
Number of contracts traded	2060
Turnover in Rs. Lakhs	17115
Open Interest	10770780.00
Change in O I	-42920.00
% Change in O I	-0.40 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	62
Price	1943.90

Best Bid

Best Offer

Quantity	425
Price	1948.3

Quantity	425
Price	1951.6

Holding Details

Latest Corporate Events

Bonus

1 : 1

11-Aug-06

Book Closure

05-Aug-20

12-Aug-20

Dividend

600 %

25-Jul-25

Company News

06-09-2025

Lupin informs about disc...

06-09-2025

USFDA concludes PAI at Lu...

03-09-2025

Lupin gets USFDA’s nod fo...

29-08-2025

Lupin informs about updat...

20-08-2025

Lupin launches Bosentan T...

20-08-2025

Lupin informs about press...

12-08-2025

Lupin partners with Sando...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.